Kerstin Siegmund

8PUBLICATIONS
19CO-AUTHORS
Haematological tumoursMedical infection agents (incl. prions)Tumour immunologyMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 13, 2026
Cblb Gene Editing in T Cells Sustains Expansion and Immunogenic CAR T Tumor Killing Under Chronic Antigenic Stimulation.

|Nov 27, 2025
Inhibition of PKCθ Abrogates CD8+ T Cell-Mediated Neurotoxicity in Murine Cerebral Malaria.

Karin Albrecht-Schgör, Victoria E Stefan, Martina Steinlechner

|Aug 13, 2025
NR2F6 as a Disease Driver and Candidate Therapeutic Target in Experimental Cerebral Malaria.

Victoria E Stefan, Victoria Klepsch, Nikolaus Thuille

|May 27, 2024
T cell-intrinsic PKD3 fine-tunes differentiation into CD8+ central memory T cells and CD8 single positive thymocyte development.

Jiří Koutník, Sebastian Peer, Dominik Humer

|May 28, 2022
A MLR-Based Approach to Analyze Regulators of T Lymphocyte Activation In Vivo.

Jiří Koutník, Victoria Klepsch, Maria Pommermayr

|Jun 02, 2021
Emerging Next-Generation Target for Cancer Immunotherapy Research: The Orphan Nuclear Receptor NR2F6.

Victoria Klepsch, Kerstin Siegmund, Gottfried Baier

Pageof 2

Frequent Collaborators

6 joint publications

Gottfried Baier

5 joint publications

Victoria Klepsch

4 joint publications

Sebastian Peer

3 joint publications

Jiří Koutník